NEW YORK (360Dx) — Akers Biosciences said today that it has signed a sales and marketing agreement with independent sales representative (ISR) firm Appleton Medical Services for its rapid test for heparin-induced thrombocytopenia (HIT).

Akers Bio's PIFA Heparin/PF4 Rapid Assay is designed to quickly determine if a patient may be developing thrombocytopenia while being treated with the blood thinner heparin at or near the point of care.